14.01 stock price down
Change
- 0.40 (2.78%)
Volume
6,500
Exchange
NASDAQ
3:59 PM ET on Apr 17, 2014
Delayed at least 20 minutes.
Provided by eSignal.
4.88 stock price up
Change
+ 0.03 (0.70%)
Volume
19,323
Exchange
TASE
11:24 AM IT on Apr 17, 2014
Delayed at least 20 minutes.
Provided by eSignal.
View all »Recent Releases

Apr 7, 2014
RedHill Biopharma Announces Positive European Scientific Advice Meeting Regarding RHB-102 and Plans to Submit a European Marketing Application

Mar 7, 2014
RedHill Biopharma to Present at the 26th Annual ROTH Conference

Mar 7, 2014
RedHill Biopharma Provides Update on RHB-102 Development and Intellectual Property

View all »Upcoming Events & Presentations

May 7, 2014 - May 8, 2014
ChinaBio Partnering Forum 2014
Kempinski Hotel Suzhou

May 11, 2014
Oppenheimer 15th Annual Israeli Conference
David Intercontinental Hotel

Investor Relations (US):

Lauren Glaser
Vice President
The Trout Group LLC
Direct: +1 646 378 2972
Cell: +1 215 740 8468
email: lglaser@troutgroup.com

Investor Relations (Israel):

Eran Gabay
Vice President & Managing Director
Financial PR and Strategic Communications
Gelbart-Kahana Investor Relations
Direct: +972 (0)3 6070 591
email: erang@gk-biz.com

General:

RedHill Biopharma Ltd.
21 Ha’arba’a St., Tel-Aviv 64739, Israel
Tel: +972 (0)3 541 3131
Fax: +972 (0)3 541 3144
email: info@redhillbio.com